Author:
Liang Qing,Cai Wuyang,Zhao Yaxue,Xu Huanbai,Tang Huirong,Chen Daijie,Qian Feng,Sun Lei
Funder
National Natural Science Foundation of China
Reference48 articles.
1. Efficacy and safety of nintedanib for the treatment of idiopathic pulmonary fibrosis: an update;Rodriguez-Portal;Drugs R.,2018
2. Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis;Meyer;Expert Rev. Respir. Med.,2017
3. Prognosis of small cell lung Cancer with idiopathic pulmonary fibrosis: assessment according to GAP stage;Song;J. Oncol.,2019
4. Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care;Harari;Intern. Emerg. Med.,2019
5. Idiopathic pulmonary fibrosis: current status, recent progress, and emerging targets;Liu;J. Med. Chem.,2017
Cited by
111 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献